IP Verse

Compositions For The Treatment Of Gastrointestinal Inflammation - EP3354276

The patent EP3354276 was granted to Meritage Pharma on Jan 1, 2020. The application was originally filed on Nov 12, 2008 under application number EP17210162A. The patent is currently recorded with a legal status of "Revoked".

EP3354276

MERITAGE PHARMA
Application Number
EP17210162A
Filing Date
Nov 12, 2008
Status
Revoked
Apr 15, 2022
Publication Date
Jan 1, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

AECHTEROct 1, 2020TER MEER STEINMEISTER & PARTNERADMISSIBLE
DR FALK PHARMASep 23, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS4900552
DESCRIPTIONUS5814330
DESCRIPTIONUS6306789
DESCRIPTIONUS6348502
DESCRIPTIONUS6509028
DESCRIPTIONUS6562363
DESCRIPTIONUS6638521
OPPOSITIONFR2884422
OPPOSITIONUS2004228919
OPPOSITIONUS2007111978
OPPOSITIONUS3539365
OPPOSITIONWO2009064819
OPPOSITIONWO9609829
SEARCHUS2007111978

Non-Patent Literature (NPL) Citations (58) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ACEVES et al., Am J Gastroenterol., (20071000), vol. 102, no. 10, pages 2271 - 9
DESCRIPTION- ACEVES S; NEWBURY, RO; DOHIL R; SCHWIMMER J; BASTIAN J., "Distinguishing Eosinophilic Esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder", Journal of Clinical Gastroenterology, (20060000), vol. 41, no. 3, pages 252 - 6
DESCRIPTION- ACEVES, SS; BASTIAN JF; NEWBURY, RO; DOHIL, R., "Oral viscous budesonide: A potential new therapy for eosinophilic esophagitis", Amer. Journal of Gastroenterology, (20070000), vol. 102, pages 1 - 9
DESCRIPTION- BUDIN C; VILLARD-TRUC F; RIVET C et al., "Eosinophilic esophagitis: 3 case reports", Gastroenterol. Clin. Biol., (20050000), vol. 29, pages 73 - 5
DESCRIPTION- CHERIAN S; SMITH N M; FORBES D A., "Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia", Arch. Dis. Child, (20060000), vol. 91, pages 1000 - 4
DESCRIPTION- CHEUNG K M; OLIVER M R; CAMERON D J et al., "Esophageal eosinophilia in children with dysphagia", J. Pediatr. Gastroenterol. Nutr., (20030000), vol. 37, pages 498 - 503
DESCRIPTION- CROESE J; FAIRLEY S K; MASSON J W et al., "Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest", Endosc., (20030000), vol. 58, pages 516 - 22
DESCRIPTION- FOGG M I; RUCHELLI E; SPERGEL J M., "Pollen and eosinophilic esophagitis", J. Allergy Clin. Immunol., (20030000), vol. 112, pages 796 - 7
DESCRIPTION- FOX V L; NURKO S; FURUTA G T., "Eosinophilic esophagitis: it's not just kid's stuff. Gastrointest", Endosc., (20020000), vol. 56, pages 260 - 70
DESCRIPTION- GUAJARDO J R; PLOTNICK L M; FENDE J M et al., "Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry", J. Pediatr., (20020000), vol. 141, pages 576 - 81
DESCRIPTION- LIACOURAS C A., Eosinophilic esophagitis: treatment in 2005. Curr. Opin. Gastroenterol., (20060000), vol. 22, pages 147 - 152
DESCRIPTION- LIACOURAS C A; RUCHELLI E., "Eosinophilic esophagitis", Cuff. Opin. Pediatr., (20040000), vol. 16, pages 560 - 6
DESCRIPTION- LIACOURAS C A; WENNER W J; BROWN K; RUCHELLI E., "Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids", J. Pediatr. Gastroenterol. Nutr., (19980000), vol. 26, pages 380 - 5
DESCRIPTION- MUELLER S; AIGNER T; NEUREITER D; STOLTE M., "Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective comparative study on pathologic biopsy", J. Clin. Pathol., (20060000), vol. 59, pages 1175 - 80
DESCRIPTION- NOEL R J; PUTNAM P E; ROTHENBERG M E., "Eosinophilic esophagitis", N. Engl. J. Med., (20040000), vol. 351, pages 940 - 1
DESCRIPTION- ORENSTEIN S R; SHALABY T M; DI LORENZO C et al., "The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children", Am. J. Gastroenterol, (20000000), vol. 95, pages 1422 - 30
DESCRIPTION- PARFITT J R; GREGOR J C; SUSKIN N G et al., "Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients", Mod. Pathol., (20060000), vol. 19, pages 90 - 6
DESCRIPTION- PLAZA-MARTIN, AM; JIMENEZ-FEIJOO R; ANDALUZ C; GINER-MUNOZ MT; MARTIN-MATEOS MA; PIQUER-GIBERT M; SIERRA-MARTINEZ JI, "Polysensitization to aeroallergens and food in eosinophilic esophagitis in a pediatric population", Alergol. Immunopathol., (20070000), vol. 35, pages 35 - 7
DESCRIPTION- RAVELLI A M; VILLANACCI V; RUZZENENTI N et al., "Dilated Intercellular Spaces: A Major Morphological Feature of Esophagitis", J. Pediatr. Gastroenterol. Nutr., (20060000), vol. 42, pages 510 - 515
DESCRIPTION- ROTHENBERG M E., "Eosinophilic gastrointestinal disorders", J. Allergy Clin. Immunol., (20040000), vol. 113, pages 11 - 28
DESCRIPTION- ROTHENBERG M E; MISHRA A; COLLINS M H; PUTNAM P E.; PATHOGENESIS AND CLINICAL FEATURES OF EOSINOPHILIC ESOPHAGITIS, J. Allergy Clin. Immunol., (20010000), vol. 108, pages 891 - 4
DESCRIPTION- RUCHELLI E; WENNER W; VOYTEK T et al., "Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy", Pediatr. Dev. Pathol., (19990000), vol. 2, pages 15 - 8
DESCRIPTION- SANT'ANNA A M; ROLLAND S; FOURNET J C et al., "Eosinophilic Esophagitis in Children: Symptoms, Histology and pH Probe Results", J. Pediatr. Gastroenterol. Nutr., (20040000), vol. 39, pages 373 - 377
DESCRIPTION- SPERGEL J M; ANDREWS T; BROWN-WHITEHORN T F et al., "Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests", Ann. Allergy Asthma Immunol., (20050000), vol. 95, pages 336 - 43, XP026959325
DESCRIPTION- SPERGEL J M; BEAUSOLEIL J L; MASCARENHAS M; LIACOURAS C A., "The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis", J. Allergy Clin. Immunol., (20020000), vol. 109, pages 363 - 8
DESCRIPTION- SPERGEL JM., "Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients", Curr. Opin. Allergy Clin. Immunol., (20070000), vol. 7, pages 274 - 8
DESCRIPTION- STEINER S J; GUPTA S K; CROFFIE J M; FITZGERALD J F., "Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring", Am. J. Gastroenterol., (20040000), vol. 99, pages 801 - 5
DESCRIPTION- STEINER S J; KERNEK K M; FITZGERALD J F., "Severity of Basal Cell Hyperplasia Differs in Reflux Versus Eosinophilic Esophagitis", J. Pediatr. Gastroenterol. Nutr., (20060000), vol. 42, pages 506 - 509
DESCRIPTION- KELLY K J; LAZENBY A J; ROWE P C et al., "Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula", Gastroenterology, (19950000), vol. 109, doi:doi:10.1016/0016-5085(95)90637-1, pages 1503 - 12, XP002672378
DESCRIPTION- KAGALWALLA A F; SENTONGO T A; RITZ S et al., "Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis", Clin. Gastroenterol. Hepatol., (20060000), vol. 4, doi:doi:10.1016/j.cgh.2006.05.026, pages 1097 - 102, XP005631216
DESCRIPTION- REMEDIOS M; CAMPBELL C; JONES D M; KERLIN P., "Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate", Gastrointest. Endosc., (20060000), vol. 63, doi:doi:10.1016/j.gie.2005.07.049, pages 3 - 12, XP005218952
DESCRIPTION- GARRETT J K; JAMESON S C; THOMSON B; COLLINS M H; WAGONER L E; FREESE, D K et al., "Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes", J. Allergy Clin. Immunol., (20040000), vol. 113, doi:doi:10.1016/j.jaci.2003.10.049, pages 115 - 9, XP002393731
DESCRIPTION- STRAUMANN A; SIMON H U., "Eosinophilic esophagitis: escalating epidemiology?", J. Allergy Clin. Immunol., (20050000), vol. 115, doi:doi:10.1016/j.jaci.2004.11.006, pages 418 - 9, XP004775701
DESCRIPTION- ACEVES S S; DOHIL R; NEWBURY R O; BASTIAN J F., "Topical viscous budesonide suspension for treatment of eosinophilic esophagitis", J. Allergy Clin. Immunol., (20050000), vol. 116, doi:doi:10.1016/j.jaci.2005.05.011, pages 705 - 6, XP005068207
DESCRIPTION- NICOLAZZO, JA; REED, BL; FINNIN, BC., "Buccal penetration enhancers - how do they really work?", J. Controlled Release, (20050000), vol. 105, doi:doi:10.1016/j.jconrel.2005.01.024, pages 1 - 15, XP004933076
DESCRIPTION- MARKOWITZ J E; SPERGEL J M; RUCHELLI E; LIACOURAS C A., "Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents", Am. J. Gastroenterol., (20030000), vol. 98, doi:doi:10.1016/S0002-9270(03)00054-6, pages 777 - 82, XP002672379
DESCRIPTION- POTTER J W; SAEIAN K; STAFF D et al., "Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest", Endosc., (20040000), vol. 59, doi:doi:10.1016/S0016-5107(03)02713-5, pages 355 - 61, XP004854169
DESCRIPTION- DESAI T K; STECEVIC V; CHANG C H et al., "Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest", Endosc., (20050000), vol. 61, doi:doi:10.1016/S0016-5107(05)00313-5, pages 795 - 801, XP005284895
DESCRIPTION- NOEL R J; PUTNAM P E; COLLINS M H et al., "Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis", Clin. Gastroenterol. Hepatol., (20040000), vol. 2, doi:doi:10.1016/S1542-3565(04)00240-X, pages 568 - 75, XP005120581
DESCRIPTION- LIACOURAS C A; SPERGEL J M; RUCHELLI E et al., "Eosinophilic esophagitis: a 10-year experience in 381 children", Clin. Gastroenterol. Hepatol., (20050000), vol. 3, doi:doi:10.1016/S1542-3565(05)00885-2, pages 1198 - 206, XP005209103
DESCRIPTION- TEITELBAUM J E; FOX V L; TWAROG F J et al., "Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate", Gastroenterology, (20020000), vol. 122, doi:doi:10.1053/gast.2002.32998, pages 1216 - 25, XP005906823
DESCRIPTION- STRAUMANN A; SPICHTIN H P; GRIZE L et al., "Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years", Gastroenterology, (20030000), vol. 125, doi:doi:10.1053/j.gastro.2003.09.024, pages 1660 - 9, XP005313646
DESCRIPTION- FURUTA, GT; LIACOURAS, CA; COLLINS, MH; SANDEEP, KG; JUSTINICH, C; PUTNAM, PE; BONIS, P; HASSALL, E; STRAUMANN, A; ROTHENBERG, ME., "Eosiniophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment", Gastroenterology, (20070000), vol. 133, doi:doi:10.1053/j.gastro.2007.08.017, pages 1342 - 1363, XP022271824
DESCRIPTION- DOHIL R; NEWBURY R O; SELLERS Z M et al., "The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine", J. Pediatr., (20030000), vol. 14, doi:doi:10.1067/S0022-3476(03)00281-6, pages 224 - 30, XP009132048
DESCRIPTION- FAUBION W A, JR.; PERRAULT J; BURGART L J et al., "Treatment of eosinophilic esophagitis with inhaled corticosteroids", J. Pediatr. Gastroenterol. Nutr., (19980000), vol. 27, doi:doi:10.1097/00005176-199807000-00016, pages 90 - 3, XP009070713
DESCRIPTION- MISHRA A; HOGAN S P; BRANDT E B; ROTHENBERG M E., "An etiological role for aeroallergens and eosinophils in experimental esophagitis", J. Clin. Invest., (20010000), vol. 107, doi:doi:10.1172/JCI10224, pages 83 - 90, XP002393729
OPPOSITION- Anonymous, "Avicel® RC-591. Microcrystalline Cellulose and Carboxymethylcellulose Sodium, NF. BP", FMC Corporation - Product Information, (19940000), pages 1 - 20, XP055739528
OPPOSITION- anonymous, "Pulmicort Respules 0.5mg - Summary of Product Characteristics (SmPC)", AstraZeneca UK Limited, (20170615), pages 1 - 9, URL: https://www.medicines.org.uk/emc/product/880/smpc/print, XP055524076
OPPOSITION- Anonymous, "Pulmicort Respules 0.5mg - Summary of Product Characteristics (SmPC)", Drug Safety Data Report - Pulmicort®, (20170615), pages 1 - 9, URL: https://www.medicines.org.uk/emc/product/880/smpc/print, XP055524076
OPPOSITION- anonymous, "RHINOCORT AQUA®", (20081101), pages 1 - 31, URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020746s024lbl.pdf, XP055524100
OPPOSITION- "Maltodextrin", Raymond C Rowe, Paul J Sheskey, Sian C Owen, HANDBOOK OF PHARMACEUTICAL EXCIPIENTS Fifth Edition, Pharmaceutical Press, (20060000), pages 2pp, 442 - 444, XP055738279
OPPOSITION- Patty McDermitt, "Avicel® CL611. Microcrystalline Cellulose and Carboxymethylcellulose Sodium, NF. BP", FMC BioPolymer - Product Information, (20140412), XP055739534
OPPOSITION- Richard D McCormick, "control of Viscosity and emulsion stability in foods using modified microcrystalline cellulose", Food Product Development, (19700000), vol. 4, no. 4, page 19, 20, 22, 26, XP001349483
OPPOSITION- Sheila M. Dell, And John A. Colliopoulos, M.S, "Avicel® RC/CL, Microcrystalline Cellulose and Carboxymethylcellulose Sodium, NF, BP", FMC Corporation, (20010000), pages 1 - 28, XP055738286
OPPOSITION- Sheila M Dell et al, "Avicel® RC/CL, Microcrystalline Cellulose and Carboxymethylcellulose Sodium, NF, BP", FMC Corporation, (20010101), pages 1 - 28, XP055738286
OPPOSITION- HANKO et al., "Determination of Sucralose in Splenda and a Sugar-Free Bever- age Using High-Performance Anion-Exchange Chromatography with Pulsed Am- perometric Detection.", J. Agric. Food Chem., (20040618), vol. 52, pages 4375 - 4379, XP055671568
OPPOSITION- SHARPE et al., "Comparison of the Flow Properties of Aqueous Suspension Cortico- steroid Nasal Sprays Under Differing Sampling Conditions", Drug Development and Industrial Pharmacy, (20030810), vol. 29, no. 9, pages 1005 - 1012, XP055739521
SEARCH- S Freers, "Maltodextrin", Handbook of Pharmaceutical Excipients - Fifth Edition, UK / USA, Pharmaceutical Press, (20060101), pages 442 - 444, ISBN 978-0-85-369618-6, XP055075444 [A] 1-15 * Monography part 7 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents